-       Report 
   - August 2025
    -  180 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - June 2025
    -  189 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - June 2025
    -  183 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - May 2025
    -  185 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - April 2025
    -  185 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                 -       Report 
   - April 2025
    -  185 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - February 2025
    -  182 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - January 2025
    -  180 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - May 2025
    -  231 Pages 
    Global
   
   From       €2247EUR$2,500USD£1,971GBP 
                  -       Report 
   - October 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                  -       Report 
   - May 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                  -       Report 
   - December 2024
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2426EUR$2,699USD£2,128GBP 
                -       Report 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2507EUR$2,789USD£2,198GBP 
                -       Report 
   - July 2025
    -  350 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Report 
   - July 2025
    -  350 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Drug Pipelines 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2507EUR$2,789USD£2,198GBP 
                -       Drug Pipelines 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2507EUR$2,789USD£2,198GBP 
                -       Report 
   - June 2025
    -  400 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
             
         The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections,    while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less   Read more